BREAST MONITOR PANEL

CA 15.3 is useful for monitoring response to treatment and if elevated suggests recurrence in women with Stage II or III breast cancer. As many as 30% of patients with breast cancer show elevated concentrations of CEA.

  • Test Type:
  • Pre-test Information:
    No special preparation required
  • Report Delivery:
    Daily
  • Components:
    0

Sample Report